Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.12M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
2.36M
-
Shares change
-
+885K
-
Total reported value, excl. options
-
$7.48M
-
Value change
-
+$2.81M
-
Number of buys
-
22
-
Number of sells
-
-1
-
Price
-
$3.18
Significant Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q4 2023
35 filings reported holding LUMO - LUMOS PHARMA INC - Common Stock as of Q4 2023.
LUMOS PHARMA INC - Common Stock (LUMO) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.36M shares
of 8.12M outstanding shares and own 29% of the company stock.
Largest 10 shareholders include WELLS FARGO & COMPANY/MN (417K shares), GOLDMAN SACHS GROUP INC (407K shares), Blackstone Inc. (327K shares), VANGUARD GROUP INC (244K shares), RENAISSANCE TECHNOLOGIES LLC (222K shares), Acuitas Investments, LLC (125K shares), Jefferies Financial Group Inc. (121K shares), Lion Point Capital, LP (90.8K shares), Greenwich Wealth Management LLC (76.3K shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (47.6K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.